jfr's therapy [80 articles] Export

Recent papers added to jfr's library classified by the tag therapy. You can also see everyone's therapy.

	A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer. [My Copy] BMC cancer, Vol. 9, No. 1. (13 May 2009), 145. by Justin M. Balko, Esther P. Black posted to therapy gene_expression egfr colon_cancer classification cetuximab by jfr on 2009-11-15 14:27:04 as along with 1 person frohike
	Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial [My Copy] J Clin Oncol (9 February 2009), JCO.2008.18.1024. by Judith Hugh, John Hanson, Maggie C. Cheang, et al.Torsten O. Nielsen, Charles M. Perou, Charles Dumontet, John Reed, Maryla Krajewska, Isabelle Treilleux, Matthieu Rupin, Emmanuelle Magherini, John Mackey, Miguel Martin, Charles Vogel posted to trial therapy subtypes breast_cancer by jfr on 2009-11-09 13:36:25 as
	American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 12. (20 April 2009), pp. 2091-2096. by Carmen J. Allegra, J. Milburn Jessup, Mark R. Somerfield, et al.Stanley R. Hamilton, Elizabeth H. Hammond, Daniel F. Hayes, Pamela K. McAllister, Roscoe F. Morton, Richard L. Schilsky posted to therapy mutation kras egfr colon_cancer by jfr on 2009-11-08 23:07:40 as along with 1 person brainsman2000
	Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. [My Copy] Breast cancer research and treatment, Vol. 108, No. 2. (March 2008), pp. 233-240. by J. C. Chang, A. Makris, M. C. Gutierrez, et al.S. G. Hilsenbeck, J. R. Hackett, J. Jeong, M. L. Liu, J. Baker, K. Clark-Langone, F. L. Baehner, K. Sexton, S. Mohsin, T. Gray, L. Alvarez, G. C. Chamness, C. K. Osborne, S. Shak posted to breast_cancer classification gene_expression rt-pcr therapy by jfr on 2009-06-24 10:01:34 as
	Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 9. (20 March 2009), pp. 1382-1387. by W. R. Miller, A. Larionov, L. Renshaw, et al.T. J. Anderson, J. R. Walker, A. Krause, T. Sing, D. B. Evans, J. M. Dixon posted to breast_cancer classification gene_expression therapy by jfr on 2009-04-29 16:05:40 as
	DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO (15 January 2009) by C Postma, M Koopman, T E E. Buffart, et al.P P P. Eijk, B Carvalho, G J J. Peters, B Ylstra, J H H. van Krieken, C J A J. Punt, G A A. Meijer posted to colon_cancer copy-number therapy by jfr on 2009-04-14 10:54:52 as along with 1 person rdiaz
	Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer [My Copy] J. Natl. Cancer Inst., Vol. 100, No. 24. (17 December 2008), pp. 1780-1791. by Davide Mauri, Nikolaos P. Polyzos, Georgia Salanti, Nicholas Pavlidis, John P. Ioannidis posted to breast_cancer meta-analysis therapy by jfr on 2009-04-09 10:45:13 as
	Advances in Breast Cancer: Pathways to Personalized Medicine [My Copy] Clin Cancer Res, Vol. 14, No. 24. (15 December 2008), pp. 7988-7999. by Olufunmilayo I. Olopade, Tatyana A. Grushko, Rita Nanda, Dezheng Huo posted to breast_cancer comment pathway personalized_medicine review therapy by jfr on 2009-04-08 15:24:21 as along with 2 people and 1 group Zephyrus misonneh Breast Cancer Reading Club
	KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 7. (1 March 2009), pp. 1130-1136. by A. Jimeno, W. A. Messersmith, F. R. Hirsch, W. A. Franklin, S. G. Eckhardt posted to colon_cancer kras mutation therapy by jfr on 2009-04-07 15:49:40 as along with 1 person aprasad
	Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. [My Copy] Cancer treatment reviews (30 December 2008) by Volker Heinemann, Sebastian Stintzing, Thomas Kirchner, Stefan Boeck, Andreas Jung posted to colon_cancer egfr kras mutation therapy by jfr on 2009-03-30 14:41:40 as
	The promises and pitfalls of RNA-interference-based therapeutics [My Copy] Nature, Vol. 457, No. 7228. (21 January 2009), pp. 426-433. by Daniela Castanotto, John J. Rossi posted to review rna-interference therapy by jfr on 2009-03-27 11:04:32 as along with 2 people sschurer ealloza
	Targeting of microRNAs for therapeutics. [My Copy] Biochemical Society transactions, Vol. 36, No. Pt 6. (December 2008), pp. 1197-1200. by J. Stenvang, M. Lindow, S. Kauppinen posted to mirna review technology therapy by jfr on 2009-03-23 15:44:57 as along with 1 group microRNA
	K-Ras mutations are changing practice in advanced colorectal cancer. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 23. (3 December 2008), pp. 1667-1669. by C. McNeil posted to colon_cancer comment kras mutation therapy by jfr on 2009-03-16 10:28:30 as
	A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities [My Copy] Proceedings of the National Academy of Sciences, Vol. 105, No. 49. (December 2008), pp. 19432-19437. by Katherine S. Garman, Chaitanya R. Acharya, Elena Edelman, et al.Marian Grade, Jochen Gaedcke, Shivani Sud, William Barry, Anna M. Diehl, Dawn Provenzale, Geoffrey S. Ginsburg, Michael B. Ghadimi, Thomas Ried, Joseph R. Nevins, Sayan Mukherjee, David Hsu, Anil Potti posted to bio_signature classification colon_cancer therapy by jfr on 2009-03-13 11:22:19 as along with 2 people misonneh sg45653
	A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial [My Copy] Breast Cancer Research and Treatment by Pascal Jézéquel, Mario Campone, Henri Roché, et al.Wilfried Gouraud, Catherine Charbonnel, Gabriel Ricolleau, Florence Magrangeas, Stéphane Minvielle, Jean Genève, Anne-Laure Martin, Régis Bataille, Loïc Campion posted to breast_cancer classification public_data therapy by jfr on 2009-03-12 11:02:35 as along with 1 person Zephyrus
	Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. [My Copy] Nature (12 November 2008) by Antoni Hurtado, Kelly A A. Holmes, Timothy R R. Geistlinger, et al.Iain R R. Hutcheson, Robert I I. Nicholson, Myles Brown, Jie Jiang, William J J. Howat, Simak Ali, Jason S S. Carroll posted to breast_cancer erbb estrogen tamoxifen therapy by jfr on 2009-02-25 18:03:16 as along with 2 people and 2 groups Zephyrus songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy. [My Copy] Breast cancer research and treatment (17 October 2008) by Katja Specht, Nadia Harbeck, Jan Smida, et al.Katja Annecke, Ulrike Reich, Joerg Naehrig, Rupert Langer, Joerg Mages, Raymonde Busch, Elisabeth Kruse, Ludger Klein-Hitpass, Manfred Schmitt, Marion Kiechle, Heinz Hoefler posted to breast_cancer classification therapy by jfr on 2009-02-20 11:19:51 as
	Introducing new molecular technologies into routine clinical cancer care: is there an impact on the treatment of breast cancer? [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 19 Suppl 7 (September 2008) by G. Bianchini, L. Gianni posted to breast_cancer markers review therapy by jfr on 2009-02-17 14:54:52 as
	Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice [My Copy] British Journal of Cancer, Vol. aop, No. current. by M. A. Pantaleo, A. Astolfi, M. Nannini, et al.P. Paterini, G. Piazzi, G. Ercolani, G. Brandi, G. Martinelli, A. Pession, A. D. Pinna, G. Biasco posted to colon_cancer gene_expression metastasis therapy by jfr on 2009-01-29 10:52:16 as
	Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer [My Copy] Breast Cancer Research, Vol. 10 (31 October 2008), 214. by Charles Swanton, Zoltan Szallasi, James D. Brenton, Julian Downward posted to classification pathway_analysis review therapy by jfr on 2009-01-07 11:36:10 as
	Models from experiments: combinatorial drug perturbations of cancer cells [My Copy] Molecular Systems Biology, Vol. 4 (02 September 2008) by Sven Nelander, Weiqing Wang, Bjorn Nilsson, et al.Qing-Bai She, Christine Pratilas, Neal Rosen, Peter Gennemark, Chris Sander posted to cell_line perturbation small_molecule systems_biology therapy by jfr on 2008-12-05 14:49:00 as along with 6 people tjchen mingzhi aheilbut ptrobajo oelemento balabu
	Determinants of RASistance to anti-epidermal growth factor receptor agents. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 10. (1 April 2008), pp. 1582-1584. by J. Baselga, N. Rosen posted to comment egfr kras therapy by jfr on 2008-11-28 14:32:07 as
	EGFR antagonists in cancer treatment. [My Copy] N Engl J Med, Vol. 358, No. 11. (13 March 2008), pp. 1160-1174. by F. Ciardiello, G. Tortora posted to egfr review therapy by jfr on 2008-11-28 14:30:00 as along with 3 people dragonrez guhjy dfp7582
	Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole. [My Copy] Pharmacogenetics and genomics, Vol. 17, No. 10. (October 2007), pp. 813-826. by W. R. Miller, A. A. Larionov, L. Renshaw, et al.T. J. Anderson, S. White, J. Murray, E. Murray, G. Hampton, J. R. Walker, S. Ho, A. Krause, D. B. Evans, J. M. Dixon posted to breast_cancer cancer classification therapy by jfr on 2008-11-26 17:55:28 as along with 1 person and 1 group Zephyrus Breast Cancer Reading Club
	Modelling Myc inhibition as a cancer therapy [My Copy] Nature (17 August 2008) by Laura Soucek, Jonathan Whitfield, Carla P. Martins, et al.Andrew J. Finch, Daniel J. Murphy, Nicole M. Sodir, Anthony N. Karnezis, Lamorna B. Swigart, Sergio Nasi, Gerard I. Evan posted to myc therapy by jfr on 2008-11-24 16:28:22 as along with 1 person sunhwan
	Data completeness[mdash]the Achilles heel of drug-target networks [My Copy] Nat Biotech, Vol. 26, No. 9. (September 2008), pp. 983-984. by Jordi Mestres, Elisabet Gregori-Puigjane, Sergi Valverde, Ricard V. Sole posted to comment network therapy by jfr on 2008-11-21 10:32:23 as along with 3 people mingzhi apocapoc ptrobajo
	KRAS mutation signature in colorectal tumors significantly overlaps with the cetuximab response signature. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 13. (1 May 2008) by A. de Reyniès, V. Boige, G. Milano, J. Faivre, P. Laurent-Puig posted to colon_cancer egfr kras letter therapy by jfr on 2008-11-19 11:12:43 as
	PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. [My Copy] Cancer research, Vol. 68, No. 6. (15 March 2008), pp. 1953-1961. by M. Jhawer, S. Goel, A. J. Wilson, et al.C. Montagna, Y. H. Ling, D. S. Byun, S. Nasser, D. Arango, J. Shin, L. Klampfer, L. H. Augenlicht, R. Perez-Soler, R. P. Soler, J. M. Mariadason posted to colon_cancer egfr kras pik3ca pten therapy by jfr on 2008-11-18 16:01:21 as
	K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer [My Copy] N Engl J Med, Vol. 359, No. 17. (23 October 2008), pp. 1757-1765. by Christos S. Karapetis, Shirin Khambata-Ford, Derek J. Jonker, et al.Chris J. O'Callaghan, Dongsheng Tu, Niall C. Tebbutt, R. John Simes, Haji Chalchal, Jeremy D. Shapiro, Sonia Robitaille, Timothy J. Price, Lois Shepherd, Heather-Jane Au, Christiane Langer, Malcolm J. Moore, John R. Zalcberg posted to colon_cancer kras mutation therapy by jfr on 2008-11-18 15:59:26 as along with 3 people morgmonster oelemento jbhiatt
	Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach? [My Copy] Expert Review of Anticancer Therapy, Vol. 8, No. 9. (September 2008), pp. 1471-1480. by Fakih, Marwan posted to colon_cancer egfr review therapy by jfr on 2008-11-10 13:58:01 as
	Breast cancer stem cells: implications for therapy of breast cancer [My Copy] Breast Cancer Research, Vol. 10 (22 July 2008), 210. by Brian J. Morrison, Chris W. Schmidt, Sunil R. Lakhani, Brent A. Reynolds, Alejandro J. Lopez posted to breast_cancer review stem_cell therapy by jfr on 2008-11-07 09:54:38 as along with 1 person and 1 group Zephyrus Breast Cancer Reading Club
	Mechanisms of Disease: oncogene addiction\|[mdash]\|a rationale for molecular targeting in cancer therapy [My Copy] Nature Clinical Practice Oncology, Vol. 3, No. 8. (01 August 2006), pp. 448-457. by I. Bernard Weinstein, Andrew K. Joe posted to oncogene_addiction review therapy by jfr on 2008-11-06 11:24:52 as along with 2 people saradtc guhjy
	Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. [My Copy] Pharmacological research : the official journal of the Italian Pharmacological Society, Vol. 56, No. 3. (September 2007), pp. 248-253. by L. Rossi, E. Bonmassar, I. Faraoni posted to colon_cancer mirna therapy by jfr on 2008-11-05 10:54:23 as
	Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells. [My Copy] Cancer letters, Vol. 270, No. 1. (18 October 2008), pp. 156-163. by H. Y. Zhao, A. Ooyama, M. Yamamoto, et al.R. Ikeda, M. Haraguchi, S. Tabata, T. Furukawa, X. F. Che, K. Iwashita, T. Oka, M. Fukushima, M. Nakagawa, M. Ono, M. Kuwano, S. Akiyama posted to colon_cancer mirna myc therapy by jfr on 2008-11-05 09:42:31 as
	Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation. [My Copy] European journal of cancer (Oxford, England : 1990), Vol. 44, No. 12. (August 2008), pp. 1754-1760. by J. T. Auman, R. Church, S. Y. Lee, M. A. Watson, J. W. Fleshman, H. L. Mcleod posted to colon_cancer gene_expression therapy by jfr on 2008-10-14 18:01:04 as
	K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 15. (1 August 2008), pp. 4830-4835. by M. C. Etienne-Grimaldi, J. L. Formento, M. Francoual, et al.E. François, P. Formento, N. Renée, P. Laurent-Puig, M. Chazal, D. Benchimol, J. R. Delpero, C. Letoublon, D. Pezet, J. F. Seitz, G. Milano posted to colon_cancer kras mutation therapy by jfr on 2008-10-08 15:23:23 as
	PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO (31 July 2008) by F Perrone, A Lampis, M Orsenigo, et al.M Di Bartolomeo, A Gevorgyan, M Losa, M Frattini, C Riva, S Andreola, E Bajetta, L Bertario, E Leo, M A A. Pierotti, S Pilotti posted to colon_cancer egfr mutation pten therapy by jfr on 2008-10-07 16:40:19 as
	Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy [My Copy] British Journal of Cancer, Vol. aop, No. current. (20 March 2007) by F. Di Fiore, F. Blanchard, F. Charbonnier, et al.F. Le Pessot, A. Lamy, M. P. Galais, L. Bastit, A. Killian, R. Sesboue, J. J. Tuech, A. M. Queuniet, B. Paillot, J. C. Sabourin, F. Michot, P. Michel, T. Frebourg posted to colon_cancer kras mutations therapy by jfr on 2008-09-29 14:19:08 as
	Evaluation of biological pathways involved in chemotherapy response in breast cancer [My Copy] Breast Cancer Research, Vol. 10 (29 April 2008), R37. by Attila Tordai, Jing Wang, Fabrice Andre, et al.Cornelia Liedtke, Kai Yan, Christos Sotiriou, Gabriel N. Hortobagyi, Fraser W. Symmans, Lajos Pusztai posted to breast_cancer pathway_analysis therapy by jfr on 2008-09-04 14:36:41 as along with 1 person and 2 groups Zephyrus Breast Cancer Reading Club Breast cancer
	Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy. [My Copy] Nature clinical practice. Oncology, Vol. 3, No. 11. (November 2006), pp. 621-632. by F. Andre, L. Pusztai posted to breast_cancer classification review therapy by jfr on 2008-09-04 10:13:01 as
	Tumor mRNA expression profiles predict responses to chemotherapy. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 28. (1 October 2007), pp. 4329-4336. by J. D. Minna, L. Girard, Y. Xie posted to classification editorial therapy by jfr on 2008-09-04 10:11:32 as
	Prediction of the outcome of preoperative chemotherapy in breast cancer by DNA probes that convey information on both complete and non complete responses [My Copy] BMC Bioinformatics, Vol. 9 (15 March 2008), 149. by Rene Natowicz, Roberto Incitti, Euler G. Horta, et al.Benoit Charles, Philippe Guinot, Kai Yan, Charles Coutant, Fabrice Andre, Lajos Pusztai, Roman Rouzier posted to breast_cancer classification therapy by jfr on 2008-09-03 14:26:54 as along with 3 people Zephyrus henryk69 Natowicz
	Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen. [My Copy] Breast cancer research and treatment, Vol. 113, No. 2. (4 January 2009), pp. 275-283. by M. Kok, S. C. Linn, R. K. Van Laar, et al.M. P. Jansen, T. M. van den Berg, L. J. Delahaye, A. M. Glas, J. L. Peterse, M. Hauptmann, J. A. Foekens, J. G. Klijn, L. F. Wessels, L. J. Van't Veer, E. M. Berns posted to breast_cancer classification tamoxifen therapy by jfr on 2008-09-03 13:46:23 as along with 1 person Zephyrus
	Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation [My Copy] BMC Cancer, Vol. 8 (22 January 2008), 18. by Olivier Gevaert, Frank De Smet, Toon Van Gorp, et al.Nathalie Pochet, Kristof Engelen, Frederic Amant, Bart De Moor, Dirk Timmerman, Ignace Vergote posted to classification ovarian_cancer therapy by jfr on 2008-09-03 10:53:37 as along with 1 person and 1 group frohike Bioinformatics
	A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. [My Copy] Cancer cell, Vol. 12, No. 4. (October 2007), pp. 395-402. by K. Berns, H. M. Horlings, B. T. Hennessy, et al.M. Madiredjo, E. M. Hijmans, K. Beelen, S. C. Linn, A. M. Gonzalez-Angulo, K. Stemke-Hale, M. Hauptmann, R. L. Beijersbergen, G. B. Mills, M. J. van de Vijver, R. Bernards posted to breast_cancer therapy by jfr on 2008-08-05 17:18:39 as
	American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 22, No. 16. (15 August 2004), pp. 3408-3419. by A. B. Benson, D. Schrag, M. R. Somerfield, et al.A. M. Cohen, A. T. Figueredo, P. J. Flynn, M. K. Krzyzanowska, J. Maroun, P. McAllister, E. Van Cutsem, M. Brouwers, M. Charette, D. G. Haller posted to colon_cancer stageii therapy by jfr on 2008-08-05 16:52:26 as
	A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 6. (15 March 2008), pp. 1744-1752. by M. Chanrion, V. Negre, H. Fontaine, et al.N. Salvetat, F. Bibeau, G. Mac Grogan, L. Mauriac, D. Katsaros, F. Molina, C. Theillet, J. M. Darbon posted to breast_cancer classification tamoxifen therapy by jfr on 2008-08-05 14:34:19 as along with 2 people Zephyrus winterschlaefer
	Colon cancer: update on adjuvant therapy. [My Copy] Clinical colorectal cancer, Vol. 7, No. 3. (May 2008), pp. 178-183. by M. S. Mano, F. Duhoux posted to colon_cancer review therapy by jfr on 2008-08-04 15:02:46 as
	Adjuvant therapy in stage II colon cancer: current approaches. [My Copy] The oncologist, Vol. 10, No. 5. (May 2005), pp. 325-331. by L. Baddi, A. Benson posted to colon_cancer review therapy by jfr on 2008-08-04 14:54:11 as
	Linking oncogenic pathways with therapeutic opportunities [My Copy] Nature Reviews Cancer, Vol. 6, No. 9. (17 August 2006), pp. 735-741. by Andrea H. Bild, Anil Potti, Joseph R. Nevins posted to bio_signature classification pathway_analysis review therapy by jfr on 2008-07-22 10:21:29 as along with 4 people aviad_work jackjackjjj frohike srp33

Note: You may cite this page as: http://www.citeulike.org/user/jfr/tag/therapy

Result page: 1 2 Next

breast_cancer	472
review	343
mirna	338
software	274
classification	271
colon_cancer	230
gene_expression	174
methodology	169
copy-number	160
network	148
integration	137
microarray_technology	133
bioinformatics	121
clustering	120
feature_selection	105
meta-analysis	94
affy	86
database	81
therapy	80
mirna_target	75
array-cgh	69
crc_bib	69
gene_set_analysis	69
low_level	66
regulation	66
systems_biology	63
pathway_analysis	60
rt-pcr	60
genomics	59
subtypes	58
annotation	57
snp-arrays	57
comment	52
quality_control	48
metastasis	45
normalization	44
mutations	43
deep_sequencing	42
ffpe	41
prognosis	41
estrogen	40
microarray_analysis	40
cancer	38
proteomics	38
bioconductor	37
statistics	37
alternative_splicing	35
markers	35
progression	35
protein_interaction	35
fdr	34
snp	33
methylation	32
r	29
class_discovery	28
mutation	28
tamoxifen	28
standards	27
exon_arrays	25
jfrbib	24
microarray_protocol	23
mir17-92	23
ovarian_cancer	23
two-color	23
experiment_design	22
pathway	22
brca	21
co-expression	21
comparison	21
model	20
survival_analysis	20
tfbs	20
kras	19
p53	19
treatment	19
functional_analysis	18
platform_comparison	18
technology	17
chip-chip	16
evaluation	16
illumina	16
jfrbib04-09	16
module_detection	16
multiple_testing	16
stem_cell	16
antisense	15
biomarker	15
nmf	15
text-mining	15
basal_subtype	14
erbb	14
reproducible_research	14
sequencing	14
bio_signature	13
egfr	13
lung_cancer	13
rna_quality	13
stageii	13
staging	13
tma	13
cnv	12
gene_ontology	12
genotyping	12
maqc	12
marker	12
cell_line	11
drug_discovery	11
loh	11
missing_values	11
proliferation	11
protocol	11
semantic_web	11
control_genes	10
disease_genes	10
gene_lists	10
genome_browser	10
pten	10
tissue_specificity	10
visualization	10
immunohistochemistry	9
mirna_regulation	9
msi	9
probe_design	9
segmentation	9
tgfb	9
boutique_arrays	8
can_genes	8
chip-seq	8
consensus_clustering	8
e2f1	8
inter-laboratory	8
personalized_medicine	8
sample_size	8
time-course	8
18q_loh	7
chemotherapy	7
lymphoma	7
myc	7
tiling_array	7
validation	7
community	6
correlation	6
editorial	6
gene_interaction	6
graphs	6
hpc	6
leukemia	6
mir21	6
motif	6
nci60	6
non-coding	6
ontology	6
plos_rules	6
promoters	6
read_mapping	6
serum	6
stem	6
cin	5
cross-platform	5
functional_genomics	5
gene_pairs	5
grid_computing	5
gwas	5
her2	5
machine_learning	5
plos_primer	5
plos_start	5
prioritization	5
prostate_cancer	5
radiation	5
trial	5
biobank	4
data_curation	4
er	4
functional_classification	4
go	4
grading	4
image_analysis	4
lims	4
mir34	4
mirna_cluster	4
pooling	4
public_data	4
resource	4
survival	4
web_services	4
agilent	3
apc	3
bim	3
biomarkers	3
chromatin	3
confounders	3
copa	3
er-positive	3
evolution	3
glioblastoma	3
hapmap	3
interaction	3
loops	3
mage	3
mass_spec	3
micro_environment	3
mir192	3
ontologies	3
open-source	3
outlier	3
pca	3
pik3ca	3
pr	3
primer	3
roc	3
sage	3
small_molecule	3
sop	3
stability	3
stroma	3
triple_negative	3
tutorial	3
web_server	3
wnt	3
20q	2
8q24	2
alignment	2
batch-effect	2
bcatenin	2
caching	2
cdk8	2
cell_cycle	2
cetuximab	2
chemo	2
dfs	2
diagnostic	2
dna_damage	2
ephb	2
epigenetics	2
filtering	2
flow_cytometry	2
gene_fusion	2
guidelines	2
in-situ	2
letter	2
local_recurrence	2
low-level	2
luminal_subtype	2
lymphocytes	2
meeting_report	2
mir20a	2
mir215	2
mutual_information	2
ngs	2
oncomine	2
permutations	2
priors	2
projection	2
protein_microarray	2
protein_networks	2
qtl	2
ranked_lists	2
recommendation	2
rin	2
semi-supervised	2
serm	2
smad	2
snp_arrays	2
stageiii	2
svm	2
sweave	2
target	2
tbfs	2
thyroid	2
translational	2
upd	2
web_resource	2
3utr	1
454	1
aging	1
akt	1
apoptosis	1
aroma	1
asco	1
assembly	1
association_studies	1
au-rich	1
aurora_kinase	1
bambi	1
bayesian	1
beads	1
biclustering	1
bmp	1
braf	1
brain_cancer	1
cables1	1
cancer_hallmarks	1
cervical_cancer	1
circulating_tumor_cells	1
cloud_computing	1
clusterin	1
compression	1
concordance	1
cross-species	1
cross-study	1
dasl	1
dcc	1
dimension_reduction	1
disease	1
distance	1
driver_genes	1
dye_bias	1
early-stage	1
ecm	1
eno1	1
ensemble	1
ependymoma	1
erg	1
er-negative	1
est_analysis	1
estradiol	1
fantom	1
fgfr2	1
fish	1
formalization	1
formats	1
funding	1
gastric_cancer	1
gene_clusters	1
gene_function_prediction	1
gene_networks	1
genetics	1
genome_assembly	1
genoty	1
graph_approach	1
hypoxia	1
il8	1
in_situ_hybridization	1
invasion	1
latent	1
latex	1
markup	1
mcm7	1
melanoma	1
met	1
meta_analysis	1
metagene	1
microrna	1
mir101	1
mir-106b-25	1
mir126	1
mir135	1
mir143	1
mir145	1
mir155	1
mir15a	1
mir16-1	1
mir199	1
mir203	1
mir449	1
mirna221	1
mirna222	1
mirna_discovery	1
mixture_models	1
model-based	1
modules	1
mrna-seq	1
myb	1
neural_networks	1
news	1
nomogram	1
oncogene	1
oncogene_addiction	1
p21	1
pancreatic_cancer	1
passenger_genes	1
pbc	1
perturbation	1
pilot_study	1
plasma	1
power_analysis	1
prb	1
pre-post	1
python	1
randomization	1
rb	1
ret	1
rnai	1
rna-interference	1
sampling	1
selection_bias	1
shrna	1
signaling	1
simulation	1
single_cell	1
smad7	1
stem_cells	1
study_design	1
target_discovery	1
taxane	1
tcga	1
tissue_origin	1
translation	1
translocation	1
ucs	1
wiki	1

jfr's therapy [80 articles] Export

jfr's tags